USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF CARDIOVACULAR HOSPITALIZATIONS OR DEATH OR CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMANENT ATRIAL FIBRILLATION
Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular hospitalizations or death or cardiovascular events notably stroke, acute coronary syndrome or cardiovascular death in patients with permanent atrial fibrillation.本發明係關於一種決奈達隆(dronedarone)於製備用於預防患有永久性心房纖維性顫動之患者的心血管疾病住院或死亡或心血管事件(尤其係中風、急性冠心症或心血管死亡)的藥物之用途。